GSK didn't get approval early on because of challenges in making a vaccine without a certain ingredient.
The US government ordered 7.6 million doses of the vaccine from Glaxo. It will be made at the company's plant in Quebec.
Officials say the vaccine will be available starting next month.
Send pictures | Classifieds | Report A Typo |
Send Tip |
Get Alerts
Most Popular | Follow abc11 on Twitter | abc11 on Facebook
